Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Explore effective ways to cut costs on regular expenses, helping you streamline your budget and increase your savings.
21,098 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Oil prices hover near the $109 mark as March 18, 2026 unfolds with supply concerns and demand momentum in focus. This...
SkyWater Technology just posted a record revenue figure, but the CFO sold about $2.5 million worth of stock. This art...
Snap faces another disappointing quarter as ad revenue slows and user growth stalls. With mounting headwinds, many an...
Get a clear, real-world view of Ligand (LGND) 2026 earnings. This guide breaks down revenue sources, milestones, and ...
Rigetti Computing just reported a sharp revenue jump. This article breaks down what a tripling revenue figure could m...
Imagine Micron topping a trillion-dollar market cap. The market would react in unpredictable ways. This guide explain...
As Anthropic prepares an IPO, history warns that sky-high private valuations rarely translate into smooth public-mark...
SpaceX is courting attention ahead of a potential Nasdaq debut. Some ETFs offer pre-IPO exposure via SPVs, but the st...
A dad partners with a veteran newsroom executive to publish a family finance playbook and launch a nationwide tour. T...
The relationship between OpenAI and Microsoft once looked like a straightforward path to AI profits. Today, smart mon...
As July 2026 brings steady rates, households weigh HYSA against Treasury Bills for emergency funds. The decision hing...